Alphatec Hlds

Alphatec Holdings, Inc. engages in the design, development, and marketing of spinal fusion technology products and solutions for the treatment of spinal disorders. It offers intra-operative information and neuromonitoring technologies, access systems, interbody implants, fixation systems, and various biologics offerings. The company was founded on March 4, 2005 and is headquartered in Carlsbad, CA.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Alphatec (ATEC) posts robust earnings, eyes growth through innovation

Alphatec (ATEC) delivered strong financial results in Q4 2022, with revenue growth, operational improvements, and a positive outlook for 2023.
The company's focus on innovation, surgeon adoption, and profitability underscores its strategic approach to sustainable growth and market leadership.
ATEC faces challenges in margin improvement, achieving EBITDA targets, and navigating competitive consolidation in the spine space.
However, the company remains optimistic, leveraging opportunities in procedural expansion, technological innovation, and international market expansion for future success.

Alphatec (ATEC) reports stellar Q1 growth and strategic acquisitions

Alphatec (ATEC) showcased robust revenue growth, strategic acquisitions, and a focus on enhancing procedural efficiency and surgeon adoption.
While challenges exist in achieving EBITDA break-even and expanding margins, ATEC's strong performance and growth outlook present promising opportunities.
The company's emphasis on technology integration, international expansion, and increasing robotics utilization positions ATEC for future success.

Alphatec (ATEC) reports robust Q2 growth and eyes international expansion

Alphatec's Q2 performance reflects strong revenue growth, margin expansion, and market share gains driven by strategic initiatives in spine surgery. The company's focus on innovation, surgeon adoption, and geographic expansion positions it well for future growth and success in the spine market.

Alphatec (ATEC) reports robust Q3 earnings, eyes growth opportunities

Alphatec (ATEC) delivered strong financial performance in Q3 2023, driven by revenue growth, positive adjusted EBITDA, and strategic initiatives.
The company's strengths lie in its spine surgery focus, new product launches, and advancements in informatics and robotic integration.
Challenges include managing risks, balancing growth with profitability, and navigating market disruptions, while opportunities exist in expansion and technology integration.

Alphatec (ATEC) reports robust Q4 performance, eyes international expansion

Alphatec (ATEC) had a strong Q4 2023, focusing on clinical excellence and market share growth. Challenges include managing debt and sustaining momentum. Opportunities lie in international expansion and innovative product launches.

Alphatec Hlds (ATEC) reports robust Q1 performance and growth outlook

Alphatec Hlds (ATEC) delivered a strong Q1 2024 performance with significant revenue growth, surgeon adoption, and sales team confidence, underpinned by a focus on innovation and market expansion.
While facing challenges in debt management and profitability, the company's strategic outlook, financial strength, and growth drivers position it well for future success and sustained growth.
By capitalizing on opportunities in technology integration, international expansion, and market share expansion, Alphatec is poised to drive continued innovation and value creation in the spine surgery market.

Alphatec Hlds (ATEC) reports robust Q2 growth and eyes Japan expansion

Alphatec Hlds (ATEC) delivered strong financial results in Q2 2024, showcasing growth in revenue, profitability, and surgeon engagement, while focusing on innovation and clinical distinction.
The company faces challenges in achieving cash flow break-even, entering new markets like Japan, and expanding into deformity surgery, but sees opportunities in market growth and technological advancements.
Overall, Alphatec Hlds (ATEC) remains committed to advancing spine surgery through technology, attracting surgeons to advanced tools, and driving sustainable growth through strategic initiatives.

Alphatec (ATEC) excels in Q3 earnings, eyes growth opportunities

Alphatec (ATEC) reported a robust Q3 performance marked by strong revenue growth and positive adjusted EBITDA, driven by surgical and EOS revenue increases. While challenges in gross margin and cash flow breakeven exist, the company remains optimistic about long-term financial commitments and revenue growth. ATEC's strategic focus on value creation, surgeon adoption, and innovation positions it well for future success.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Alphatec Holdings, Inc. (NASDAQ:ATEC ) Q1 2023 Earnings Conference Call May 4, 2023 4:30 PM ET Company Participants Pat Miles - Chairman and CEO Todd Koning - Chief Financial Officer Conference Call Participants Matt Blackman - Stifel Brooks O'Neil - Lake Street Capital Markets Eric Anderson - TD Cowen Sean Lee - H.C. Wainwright Operator Good afternoon, everyone.

Alphatec Holdings, Inc. (ATEC) Q1 2023 Earnings Call Transcript

Alphatec (ATEC) came out with a quarterly loss of $0.40 per share versus the Zacks Consensus Estimate of a loss of $0.32. This compares to loss of $0.43 per share a year ago.

Alphatec (ATEC) Reports Q1 Loss, Tops Revenue Estimates

CARLSBAD, Calif.--(BUSINESS WIRE)--Alphatec Holdings, Inc. (Nasdaq: ATEC), a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, today announced financial results for the quarter ended March 31, 2023, and recent corporate highlights. First-Quarter 2023 Financial Results   Quarter Ended March 31, 2023 Total revenue $109 million GAAP gross margin 65% Non-GAAP gross margin 72% GAAP operating expenses $111 million Non-GAAP operating expenses $93 million GAAP.

ATEC Reports First Quarter 2023 Financial Results

Domino's Pizza

Johnson & Johnson

Martin Marietta Materials

Vontier Corporation

The world's foremost artificial intelligence stock trading algorithm, An-E, predicts that Alphatec (NASDAQ: ATEC ) stock will gain 5.5% by June 1. An-E (pronounced Annie) has made this kind of prediction before.

Artificial Intelligence Engine Predicts ATEC Stock to Gain 5.5% by June 1

Alphatec (ATEC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Will Alphatec (ATEC) Report Negative Earnings Next Week? What You Should Know

CARLSBAD, Calif.--(BUSINESS WIRE)--Alphatec Holdings, Inc. (Nasdaq: ATEC), a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, announced today the pricing of an underwritten registered offering of 4,285,715 shares of common stock (the “Shares”) at an offering price of $14.00 per share.

ATEC Announces $60 Million Underwritten Offering

PALM BEACH GARDENS, Fla., April 19, 2023 (GLOBE NEWSWIRE) -- Accelus, a privately held medical technology company focused on accelerating the adoption of minimally invasive surgery (MIS) as the standard of care in spine, has announced a leadership change and reorganization, as well as the sale of its Remi® Robotic Navigation System assets to Alphatec Holdings, Inc. (Nasdaq: ATEC).

Accelus Sells Remi Robotic Navigation System to Alphatec and Announces Leadership Change to Drive Growth and Innovation

CARLSBAD, Calif.--(BUSINESS WIRE)--Alphatec Holdings, Inc. (Nasdaq: ATEC), a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, announced today that it has acquired all assets related to the REMI Robotic Navigation System from Fusion Robotics, LLC, a privately held medical technology company, for a purchase price of $55 million.

ATEC Acquires Navigation-Enabled Robotics Platform; Raises 2023 Revenue Guidance on Strength of Preliminary First Quarter Revenue Results

CARLSBAD, Calif.--(BUSINESS WIRE)--Alphatec Holdings, Inc. (Nasdaq: ATEC), a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, announced today that it will report first quarter financial results on May 4, 2023, after the market close. The Company will host a live webcast that day at 1:30 p.m. PT / 4:30 p.m. ET. Webcast To access the live webcast, please visit the Investor Relations Section of ATEC's Corporate Website.

ATEC to Report First Quarter 2023 Financial Results on May 4, 2023

SVB Financial Group

Shares of Alphatec Holdings Inc. ATEC, gained 0.2% in morning trading Monday, after the California-based spinal fusion technology company disclosed that it had $14 million deposited with SVB Financial Group's SIVB, Silicon Valley Bank for use for its day-to-day operations. That represented about 16.5% of the $84.7 million Alphatec had in cash and cash equivalents as of Dec. 31.

Alphatec's $14 million deposited with SVB represents more than 16% of its cash, cash equivalents

Alphatec Holdings, Inc. (NASDAQ:ATEC ) Q4 2022 Results Conference Call February 28, 2023 4:30 PM ET Company Participants Pat Miles - Chairman and CEO Todd Koning - CFO Conference Call Participants Drew Ranieri - Morgan Stanley Brooks O'Neil - Lake Street Capital Markets Kyle Rose - Canaccord David Saxon - Needham & Company Sean Lee - H.C. Wainwright Operator Good afternoon, everyone.

Alphatec Holdings, Inc. (ATEC) Q4 2022 Earnings Call Transcript

CARLSBAD, Calif.--(BUSINESS WIRE)--Alphatec Holdings, Inc. (Nasdaq: ATEC), a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, today announced financial results for the quarter and full year ended December 31, 2022, and recent corporate highlights.

ATEC Reports Record Fourth Quarter and Full-Year 2022 Financial Results and Recent Corporate Highlights

Alphatec (ATEC) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.

Alphatec (ATEC) Soars 8.4%: Is Further Upside Left in the Stock?

ATEC to Report Fourth Quarter and Fiscal Year 2022 Financial Results on February 28, 2023

CARLSBAD, Calif.--( BUSINESS WIRE )--Alphatec Holdings, Inc. (Nasdaq: ATEC), a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, announced today select preliminary financial results for the fourth quarter and full year ended December 31, 2022, and provided guidance for full-year 2023 revenue and adjusted EBITDA. The Company also announced the closing of a five-year, $150 million non-dilutive term loan agreement with Braidwell LP, a life science focused firm.

ATEC Announces Select Preliminary Financial 2022 Results, 2023 Guidance and Closing of Flexible, Non-Dilutive Debt Facility

Alphatec has broken out to the upside following a charge off its July FY22 lows. The rally has extended to the present day, and we examined to see if it has the legs to extend further.

Examining The Recent Breakout For Alphatec Holdings (Technical Analysis)

CARLSBAD, Calif.--( BUSINESS WIRE )--Alphatec Holdings, Inc. (Nasdaq: ATEC), a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, announced today that management will virtually participate in the 25th Annual Needham Growth Conference with a fireside chat on January 12, 2023, at 3:00p.m. ET. The webcast of the presentation and an archived recording will be available in the Investor Relations Section of the Company's website.

ATEC to Participate in Upcoming Investor Conference

Alphatec Holdings, Inc. (NASDAQ:ATEC ) Q3 2022 Earnings Conference Call November 3, 2022 4:30 PM ET Company Participants Pat Miles - Chairman and Chief Executive Officer Todd Koning - Chief Financial Officer Conference Call Participants Phillip Dantoin - Piper Sandler Young Li - Jefferies Brooks O'Neil - Lake Street Capital Markets Drew Ranieri - Morgan Stanley Eric Anderson - Cowen Caitlin Cronin - Canaccord Genuity David Saxon - Needham & Company Jason Wittes - Loop Capital Operator Good afternoon, everyone and welcome to the webcast of ATEC's Third Quarter Financial Results. We would like to remind everyone that participants on the call will make forward-looking statements.

Alphatec Holdings, Inc. (ATEC) Q3 2022 Earnings Call Transcript

ATEC Reports Third Quarter 2022 Financial Results

Alphatec has seen solid growth in its spine business. Strong growth is very encouraging, yet lack of margin developments make me very hesitant.

Alphatec: Not Having My Back (Yet)

ATEC Launches Expandable Technology for Medialized Posterior Procedure

CARLSBAD, Calif.--(BUSINESS WIRE)--Alphatec Holdings, Inc. (Nasdaq: ATEC), a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, announced today that the Company will introduce at the 2022 NASS Annual Meeting innovation designed to improve lateral surgery. The Company has applied learnings from Prone TransPsoas (PTPTM) and decades of lateral prowess to evolve both the Lateral TransPsoas (LTPTM) and the orthogonal Midline ALIFTM approaches with novel tech

ATEC Advances Lateral Sophistication

CARLSBAD, Calif.--(BUSINESS WIRE)--Alphatec Holdings, Inc. (Nasdaq: ATEC), a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, announced today select preliminary financial results for the third quarter ended September 30, 2022, and updated full-year 2022 revenue guidance ahead of investor meetings scheduled during the 2022 North American Spine Society (NASS) Annual Meeting. Preliminary Third Quarter 2022 Revenue Ranges   Quarter Ended September 30, 202

ATEC Announces Select Preliminary Third Quarter 2022 Financial Results and Raises Guidance

The mean of analysts' price targets for Alphatec (ATEC) points to a 76.5% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

Wall Street Analysts Believe Alphatec (ATEC) Could Rally 77%: Here's is How to Trade

Alphatec (ATEC) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road.

News for Alphatec Hlds Stock (ATEC)